No Yes Ok

Archive

« Older Entries

LSP invests in Aviadobio's $80 Million Series A Financing Wednesday, December 8th, 2021
AviadoBio’s unique platform combines next-generation gene therapy design with deep neuroscience expertise and a novel neuroanatomy-led approach to drug delivery Co-founded by leading neurologist and neuros [...]
LSP Invests in $100 M Series C of HotSpot Therapeutics Tuesday, November 30th, 2021
to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic   Financing will accelerate HotSpot's transition into a clinical development company while enabling expansion of itrs product pip [...]
PE takeout frees up LSP's team, promises bigger funds Thursday, November 18th, 2021
Amsterdam, The Netherlands, November 18, 2021 - Europe's largest life sciences VC is set to get even bigger. On the back of raising nearly $1 billion for its seventh fund, LSP is being acquired by private equity f [...]
LSP and EQT join forces in healthcare investing Wednesday, November 10th, 2021
Amsterdam, The Netherlands, November 10, 2021 — LSP, one of the leading European life sciences investors, announces today that it will join forces with EQT AB (“EQT”), one of Europe’s largest private equity fi [...]
LSP raises record $1 billion for its 7th flagship life sciences fund Thursday, November 4th, 2021
Amsterdam, The Netherlands, 4 November 2021 – LSP, a leading European life sciences investor, announces today that it has raised €850 million (~$1 billion) for its 7th generation flagship life sciences fund: LSP 7 [...]
LSP Portfolio Company DNA Script Raises $165M in Oversubscribed Series C Financing Tuesday, October 26th, 2021
New Funding, Targeted to Accelerate Application Expansion and Platform Commercialization, Brings Total Amount Raised to Date to $310M   Amsterdam, The Netherlands, 26 October 2021— LSP 6 portfolio company D [...]
LSP co-leads € 40 million ($ 46.3 million) Series A in Egle Therapeutics Friday, October 22nd, 2021
Egle will develop first-in-class immunotherapies targeting suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases Series A financing co-led by LSP and Bpifrance, through its InnoBio 2 Fun [...]
MD Anderson and SNIPR BIOME collaborate Monday, September 13th, 2021
to advance next-generation CRISPR microbiome therapeutics   Research focused on improving immunotherapy-related side effects for patients with cancer     Amsterdam, The Netherlands, 13 September [...]
LSP invests in $83 Million Series A Financing of Evommune Thursday, September 9th, 2021
To advance Development of a Unique Chronic Inflammation Pipeline Series A Comprises a Global Syndicate o Investors Including LSP, Pivotal bioVenture Partners and Andera Partners   Amsterdam, The N [...]
LSP portfolio company Nouscom announces Wednesday, August 25th, 2021
first patient dosed in a Phase 1b Trial with NOUS-PEV, a novel personalized cancer immunotherapy, in advanced melanoma or lung cancer   Amsterdam, The Netherlands, 25 August 2021 - LSP, one of Europe’s lead [...]

« Older Entries

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
Follow us

No Yes Ok

Archive

« Older Entries

LSP invests in Aviadobio's $80 Million Series A Financing Wednesday, December 8th, 2021
AviadoBio’s unique platform combines next-generation gene therapy design with deep neuroscience expertise and a novel neuroanatomy-led approach to drug delivery Co-founded by leading neurologist and neuros [...]
LSP Invests in $100 M Series C of HotSpot Therapeutics Tuesday, November 30th, 2021
to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic   Financing will accelerate HotSpot's transition into a clinical development company while enabling expansion of itrs product pip [...]
PE takeout frees up LSP's team, promises bigger funds Thursday, November 18th, 2021
Amsterdam, The Netherlands, November 18, 2021 - Europe's largest life sciences VC is set to get even bigger. On the back of raising nearly $1 billion for its seventh fund, LSP is being acquired by private equity f [...]
LSP and EQT join forces in healthcare investing Wednesday, November 10th, 2021
Amsterdam, The Netherlands, November 10, 2021 — LSP, one of the leading European life sciences investors, announces today that it will join forces with EQT AB (“EQT”), one of Europe’s largest private equity fi [...]
LSP raises record $1 billion for its 7th flagship life sciences fund Thursday, November 4th, 2021
Amsterdam, The Netherlands, 4 November 2021 – LSP, a leading European life sciences investor, announces today that it has raised €850 million (~$1 billion) for its 7th generation flagship life sciences fund: LSP 7 [...]
LSP Portfolio Company DNA Script Raises $165M in Oversubscribed Series C Financing Tuesday, October 26th, 2021
New Funding, Targeted to Accelerate Application Expansion and Platform Commercialization, Brings Total Amount Raised to Date to $310M   Amsterdam, The Netherlands, 26 October 2021— LSP 6 portfolio company D [...]
LSP co-leads € 40 million ($ 46.3 million) Series A in Egle Therapeutics Friday, October 22nd, 2021
Egle will develop first-in-class immunotherapies targeting suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases Series A financing co-led by LSP and Bpifrance, through its InnoBio 2 Fun [...]
MD Anderson and SNIPR BIOME collaborate Monday, September 13th, 2021
to advance next-generation CRISPR microbiome therapeutics   Research focused on improving immunotherapy-related side effects for patients with cancer     Amsterdam, The Netherlands, 13 September [...]
LSP invests in $83 Million Series A Financing of Evommune Thursday, September 9th, 2021
To advance Development of a Unique Chronic Inflammation Pipeline Series A Comprises a Global Syndicate o Investors Including LSP, Pivotal bioVenture Partners and Andera Partners   Amsterdam, The N [...]
LSP portfolio company Nouscom announces Wednesday, August 25th, 2021
first patient dosed in a Phase 1b Trial with NOUS-PEV, a novel personalized cancer immunotherapy, in advanced melanoma or lung cancer   Amsterdam, The Netherlands, 25 August 2021 - LSP, one of Europe’s lead [...]

« Older Entries

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
X

MONTHLY REPORTS

Here you can subscribe for the monthly report of the LSP Life Sciences Fund